Yazdan Yazdanpanah to Patient Reported Outcome Measures
This is a "connection" page, showing publications Yazdan Yazdanpanah has written about Patient Reported Outcome Measures.
Connection Strength
0.114
-
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med. 2018 03; 19(3):227-237.
Score: 0.114